INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2002

Daily antioxidant vitamin supplementation for 5 years did not reduce vascular events, cancer incidence, or mortality in high-risk UK adults.

A total of 20,536 high-risk UK adults were randomly allocated to receive daily antioxidant vitamins (600 mg vitamin E, 250 mg vitamin C, and 20 mg beta-carotene) or placebo for 5 years. There were no significant differences in all-cause mortality (14.1% vitamin vs 13.5% placebo), vascular deaths (8.6% vs 8.2%), or non-vascular deaths (5.5% vs 5.3%). Major vascular events occurred in 22.5% of participants in both the vitamin and placebo groups (event rate ratio 1.00, 95% CI 0.94-1.06). There were also no significant effects observed on cancer incidence or hospitalisation for other non-vascular causes.

Study type
Randomized placebo-controlled trial
Who was studied
20,536 UK adults aged 40-80 with coronary disease, other occlusive arterial disease, or diabetes
What was measured
All-cause mortality, major coronary events, fatal or non-fatal vascular events, cancer incidence, and other major morbidity

THE PAPER

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Heart Protection Study Collaborative Group. Lancet, 2002.

PubMed 12114037 ↗DOI 10.1016/s0140-6736(02)09328-5 ↗

Heart & arteriesCancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.